Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Depreciation & Amortization (CF) (2020 - 2025)

Celularity has reported Depreciation & Amortization (CF) over the past 6 years, most recently at $1.8 million for Q3 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $1.8 million for Q3 2025, down 3.7% from a year ago — trailing twelve months through Sep 2025 was $7.4 million (down 11.68% YoY), and the annual figure for FY2024 was $7.9 million, down 15.04%.
  • Depreciation & Amortization (CF) for Q3 2025 was $1.8 million at Celularity, down from $1.8 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for CELU hit a ceiling of $2.6 million in Q4 2021 and a floor of $1.8 million in Q3 2025.
  • Median Depreciation & Amortization (CF) over the past 5 years was $2.3 million (2022), compared with a mean of $2.2 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): surged 55.03% in 2021 and later decreased 19.16% in 2024.
  • Celularity's Depreciation & Amortization (CF) stood at $2.6 million in 2021, then fell by 6.41% to $2.4 million in 2022, then decreased by 5.86% to $2.3 million in 2023, then dropped by 18.29% to $1.9 million in 2024, then dropped by 2.77% to $1.8 million in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $1.8 million (Q3 2025), $1.8 million (Q2 2025), and $1.8 million (Q1 2025) per Business Quant data.